University of Patras
Η επίδραση της οστεοπόρωσης στους δείκτες αναπνευστικής λειτουργίας σε ασθενείς με χρόνια αποφρακτική πνευμονοπάθεια
Abstract
dc:descriptionObjective: Osteoporosis is highly prevalent among patients with chronic obstructive pulmonary disease (COPD) and most commonly presents as a vertebral compression fracture (VCF). Our objective was to quantify the effect of osteoporosis and VCFs on the mortality and pulmonary function tests (PFTs), such as forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC), of patients with COPD.Methods: Research conducted for the purposes of this thesis consisted of 2 parts. The first part consisted of a meta-analysis. A PubMed/Medline search was conducted using the search terms “chronic obstructive pulmonary disease”, “osteoporosis” and “vertebral compression fracture”. Meta-analyses were conducted to evaluate the differences in mortality and PFTs between patients with COPD with and without osteoporosis or VCFs, according to PRISMA guidelines. The second part consisted of a pilot study of COPD patients, to evaluate the presence of osteoporosis in a Greek cohort of patients with COPD.Results: Of the 896 abstracts identified, 27 studies describing 7662 patients with COPD of which 1883(24.6%) had osteoporosis or VCFs, were included. Random effects model analysis demonstrated that patients with COPD and osteoporosis or VCFs had an increased OR for mortality of 2.40 (95% CI: 1.24;4.64, I2= 89%, P < 0.01), decreased FEV1/FVC with a mean difference of −4.80% (95% CI: −6.69; −2.90,I2= 83%, P < 0.01) and decreased FEV1, with a mean difference of −4.91% (95% CI: −6.51; −3.31, I2= 95%,P < 0.01) and −0.41 L (95% CI: −0.59; −0.24, I2= 97%, P < 0.01), compared to control subjects. Apart from FEV1(liters) in subgroup 1 (P = 0.06), all subgroup analyses found significant differences between groups, as did sensitivity analysis of low risk of bias studies. Regarding the pilot study, 12 patients were included, (7 male, 5 female) with a mean age of 65 years. Of these, 3 had osteopenia and 2 had osteoporosis.Conclusion: Osteoporosis and VCFs are associated with a significant reduction in survival and pulmonary function among patients with COPD. Additional studies are required in this field to corroborate these findings in the Greek population.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kakoullis, Loukas
- Κακουλλής, Λουκάς
Subjects
dc:subject × 12- Χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ)
- Οστεοπόρωση
- Μείωση FEV1
- Chronic obstructive pulmonary disease (COPD)
- Osteoporosis
- FEV1 decline
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Πνευμονολογία και Αναπνευστικές παθήσεις
- Clinical Medicine
- Medical and Health Sciences
- Pulmonary and Respiratory Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52857